You can access today’s Stock Gumshoe revelation here … … Gum_030719Doc
About Bob Weir
3242 Articles
Bob Weir has over 50 years of investment research and analytical experience in both the equity and fixed-income sectors, and in the commercial real estate industry. He joined eResearch in 2004 and was its President, CEO, and Managing Director, Research Services until December 2018. Prior to joining eResearch, Bob was at Dominion Bond Rating Service (DBRS).
Related Articles
![ESG - Green World](https://eresearch.com/wp-content/uploads/2022/07/ESG-FI.jpg)
Clean Tech
Rebalanced ESG ETFs Index Up Last Week; Down YTD
ESG investing is not just about aligning your financial goals with your values. Studies show that ESG investing can reduce volatility and improve returns. This article highlights the performance of the 10 ETFs with the highest ESG scores over 3 time periods this year. [more]
![](https://eresearch.com/wp-content/uploads/2019/04/care-connection-device-1282308-326x245.jpg)
Health
Analyst Article: Mystery “Cancer Sniper” Company Revealed – August 19, 2018
eResearch is pleased to provide two articles written about a small cancer-killing company. The title of the article is Market Teasers. [more]
![](https://eresearch.com/wp-content/uploads/2021/03/2021-02-17-Well-Health-CRH-Medical-FI.png)
Analyst Articles
WELL Health to Triple Revenue with $369.2M CRH Medical Acquisition
WELL Health’s buying spree continues with a major acquisition with C$302.5M financing led by Mr. Li Ka-shing. The acquisition will add annual revenue of US$100M with a run-rate of US$120 million to Well Health’s books. CRH currently has an EBITDA operating margin of 40%. [more]